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Each signpost directs to a source of information which people indicated as a 
priority for change within the Northern Ireland health and social care system.
by and for the rare disease community.
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Website/hub where all rare 
disease information can be 
accessed or linked.
Central register of those 
with a rare condition.
Training for professionals.
Regular local support 
meetings.
Public health campaign 
(incl. social media).
Rare Disease Coordinator to 
make information and 
research available.
Strong inter-professional 
working between specialists 
& GPs.
Raise awareness and have 
timely reminders in the press 
about conditions.
Individualised care 
plans/patient-centred 
approach.
Research and accurate data 
gathering on those affected 
by rare disease.
A survey was conducted among individuals living and working with rare
diseases to evaluate communication for them within the healthcare
system, how individuals access or engage with medical practitioners, and
how individuals generally access information about rare diseases. Also
included were questions to help prioritise improvement within, and allied
with, communication and information processes of the integrated health
and social care system in Northern Ireland.
Considering communication on a system level, it is important to be aware that
communication can be especially challenging for those who have been
diagnosed with a rare condition. For example, isolation is described as an
immediate consequence of being diagnosed with a rare disease (Pelentsov et
al. 2016). Due to the condition being rare who can empathise with persons
living or working with the condition? Who will be able to offer suggestions or
experience? And who will have accurate or reputable information? These are
questions which are faced by many who are affected by a rare disease. Thus,
effective support networks are vital for those living and working with rare
conditions and social networks are a significant method by which
communication involving rare disease occurs (van Betuw 2010).
The Internet was the most regularly accessed source of information for rare diseases. 64.9% of
respondents accessed it regularly, where the next most regularly accessed source of information
(charity/support groups) was accessed regularly by only 48.2% of the respondents. The Internet was also
the source of information found by most respondents as very easy to access, with 58.0% of respondents
finding it very easy, and a further 29.5% respondents finding it manageable. The source found by the
second highest number of people to be very easy to access was social media with 34.8% saying that it was
very easy, and 25.0% saying it was manageable. Given that the Internet is both the most regularly
accessed and the easiest way to source information on rare disease, this highlights the problem faced by
people with rare disease who find it considerably harder to access medical professionals, information
events and conferences both local and international, and the medical literature, than they do to do a
search engine on the Internet. What affect does this have on the engagement between the patient and
the medical professional, and also on the wellbeing of the patient who is relying on information they are
sourcing themselves with no obvious credibility or reliability?
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Is there a pathway to diagnosis documented? Over a fifth of the responses to the
question of what clinical information they would like to have available about rare
diseases were about diagnosis. Diagnosis appears to be something that many of the
respondents have found difficult. It is possible that there is information available that
they are not aware of, or that in fact there is not information available at present about
the process or complexities, and timelines involved in getting diagnosis. Neither of these
possibilities are ideal. There is also a lack of information post-diagnosis about the
process to come. This means that patients may receive a letter informing them of a
diagnosis, but no information as to what the short, medium, and long term steps within
the healthcare system will be.
Further to this many respondents to the survey have found that communication between
services in the NHS doesn’t happen successfully for rare disease patients. This was not
directly addressed in any one question but was commented on in many.
Participants of the survey said that professionals not listening was a serious
problem for a person with a rare disease. The participants wanted ‘involvement of
patients as experts’, ‘empathy’, and ‘a more open mind from consultants when we
present information we have found’.
Not being patronised, not having the research they’d done taken seriously, and a 
lack of empathy have also been shown in the wider research to be a problem for 
parents who are speaking to geneticists (Anonymous 2015).  Patients need to be 
treated as partners or at least included in decisions around the healthcare options 
available or the next steps.
